Loading stock data…
Loading stock data…
US$1.10
Get one email when PLRX crosses your level. Checked every 15 minutes during market hours.
▼ -0.01 (-0.90%)down today
USD · data via Finnhub · delayed/cached up to 1–5 min
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
RSI (14-day)
43.5
NeutralAbove 70 can signal overbought; below 30, oversold.
MACD
-0.02
Bearish momentumMACD below its signal line (-0.01).
50-day average
1.17
Price belowShort-term trend reference.
200-day average
1.32
Price belowLong-term trend reference.
Daily values · indicators are descriptive, not trading advice
Healthcare · Biotechnology
Pliant Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing integrin-based therapeutics for fibrotic diseases, solid tumors, and muscular dystrophies. The company leverages integrin receptor biology to create novel small-molecule inhibitors and monoclonal antibodies that modulate key pathways like TGF-β signaling, aiming for tissue-specific targeting to address unmet needs in these areas. Its pipeline features bexotegrast, an oral dual selective i…
pliantrx.com0 strong buy · 0 buy · 6 hold · 2 sell · 2 strong sell (10 analysts, 2026-07-01)
0 strong buy · 1 buy · 6 hold · 2 sell · 2 strong sell (11 analysts, 2026-06-01)
0 strong buy · 1 buy · 6 hold · 2 sell · 2 strong sell (11 analysts, 2026-05-01)
0 strong buy · 1 buy · 6 hold · 2 sell · 2 strong sell (11 analysts, 2026-04-01)
| Quarter | Estimate | Actual | Result |
|---|---|---|---|
| 2026-05-11 | -0.36 | -0.32 | ✓ Beat |
| 2026-04-08 | 0.57 | 0.64 | ✓ Beat |
| 2026-03-11 | -0.38 | -0.35 | ✓ Beat |
| 2025-10-31 | 1.77 | 1.83 | ✓ Beat |
| 2025-08-07 | -0.68 | -0.71 | ✗ Miss |
| 2025-05-08 | -0.75 | -0.92 | ✗ Miss |
| 2025-03-03 | -0.96 | -0.82 | ✓ Beat |
Companies in the same industry, via Finnhub